Blood pressure management in acute stroke

Journal of Human Hypertension

Volumn 23, Issue 9, 2009, Pages 559-569

  Mullen, M T ^a   McKinney, J S ^a   Kasner, S E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; LABETALOL; NICARDIPINE; NIMODIPINE; PLACEBO; PROPRANOLOL;

ANTIHYPERTENSIVE THERAPY; AUTOREGULATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN PERFUSION; BRAIN VASCULAR RESISTANCE; CARDIOVASCULAR PROCEDURES; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DISEASE SEVERITY; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; HYPOTENSION; INDUCED HYPERTENSION; INTRACRANIAL PRESSURE; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION;

ALGORITHMS; BLOOD PRESSURE; BRAIN INFARCTION; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC;

EID: 69549096244     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.164     Document Type: Review

References (91)

1. Qureshi AI, Suri MF, Nasar A, Kirmani JF, Ezzeddine MA, Divani AA et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990-1991 and those hospitalized in 2000-2001. Stroke 2007; 38(7): 2180-2184.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N et al. Heart disease and stroke statistics - 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117(4): E25-e146.
3. Williams GR. Incidence and characteristics of total stroke in the United States. BMC Neurol 2001; 1: 2.
4. International cardiovascular disease statistics (2008 Update). Available at: http://www.americanheart.org/downloadable/heart/ 1201543457735FS06INT08.pdf. Accessed 30 September 2008.
5. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33(5): 1315-1320.
6. Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM et al. Prevalence of elevated blood pressure in 563 704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 2007; 25(1): 32-38.
7. Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246(19): 2177-2180.
8. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension 2004; 43(1): 18-24.
9. Rodriguez-Yanez M, Castellanos M, Blanco M, Garcia MM, Nombela F, Serena J et al. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology 2006; 67(11): 1973-1978.
10. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008; 118(2): 176-187.
11. Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: A tertiary analysis of the GAIN international trial. Stroke 2003; 34(10): 2420-2425.
12. Mattle HP, Kappeler L, Arnold M, Fischer U, Nedeltchev K, Remonda L et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005; 36(2): 264-268.
13. Obrist WD, Langfitt TW, Jaggi JL, Cruz J, Gennarelli TA. Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension. J Neurosurg 1984; 61 (2): 241-253.
14. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959; 39(2): 183-238.
15. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976; 53(4): 720-727.
16. Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973; 1 (5852): 507-510.
17. Dawson SL, Panerai RB, Potter JF. Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis 2003; 16(1): 69-75.
18. Olsen TS, Larsen B, Herning M, Skriver EB, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke 1983; 14(3): 332-341.
19. Christensen H, Meden P, Overgaard K, Boysen G. The course of blood pressure in acute stroke is related to the severity of the neurological deficits. Acta Neurol Scand 2002; 106(3): 142-147.
20. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet 1994; 344(8916): 156-159.
21. Stead LG, Gilmore RM, Decker WW, Weaver AL, Brown Jr RD. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology 2005; 65(8): 1179-1183.
22. Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 1993; 24(9): 1372-1375.
23. Stead LG, Gilmore RM, Vedula KC, Weaver AL, Decker WW, Brown Jr RD. Impact of acute blood pressure variability on ischemic stroke outcome. Neurology 2006; 66(12): 1878-1881.
24. Yong M, Kaste M. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial. Stroke 2008; 39(2): 366-372.
25. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004; 35(2): 520-526.
26. Semplicini A, Maresca A, Boscolo G, Sartori M, Rocchi R, Giantin V et al. Hypertension in acute ischemic stroke: A compensatory mechanism or an additional damaging factor? Arch Intern Med 2003; 163 (2): 211-216.
27. Oliveira-Filho J, Silva SC, Trabuco CC, Pedreira BB, Sousa EU, Bacellar A. Detrimental effect of blood pressure reduction in the first 24 h of acute stroke onset. Neurology 2003; 61(8): 1047-1051.
28. Fischberg GM, Lozano E, Rajamani K, Ameriso S, Fisher MJ. Stroke precipitated by moderate blood pressure reduction. J Emerg Med 2000; 19(4): 339-346.
29. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke ('BEST' trial): An evaluation. Br Med J (Clin Res Ed) 1988; 296(6624): 737-741.
30. Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000; 31 (6): 1250-1255.
31. Horn J, Limburg M. Calcium antagonists for ischemic stroke: A systematic review. Stroke 2001; 32(2): 570-576.
32. The Blood pressure in Acute Stroke Collaboration (BASC). Vasoactive drugs for acute stroke. Cochrane Database Syst Rev 2000; (4): CD002839.
33. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke 1999; 30(2): 287-292.
34. Bowes MP, Zivin JA, Thomas GR, Thibodeaux H, Fagan SC. Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Exp Neurol 1996; 141(1): 40-46.
35. Fagan SC, Bowes MP, Lyden PD, Zivin JA. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: Effect of labetalol. Exp Neurol 1998; 150(1): 153-158.
36. Elewa HF, Kozak A, Johnson MH, Ergul A, Fagan SC. Blood pressure lowering after experimental cerebral ischemia provides neurovascular protection. J Hypertens 2007; 25(4): 855-859.
37. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003; 34 (12): 2922-2929.
38. Sigurdsson ST, Strandgaard S. Blood pressure lowering in acute ischaemic stroke: An update on the role of angiotensin receptor blockers. J Hypertens 2007; 25(4): 743-745.
39. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J et al. The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34(7): 1699-1703.
40. Eveson DJ, Robinson TG, Potter JF. Lisinopril for the treatment of hypertension within the first 24 h of acute ischemic stroke and follow-up. Am J Hypertens 2007; 20(3): 270-277.
41. Bath PM, Willmot M, Leonardi-Bee J, Bath FJ. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev 2002; (4): CD000398.
42. Brott T, Lu M, Kothari R, Fagan SC, Frankel M, Grotta JC et al. Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998; 29(8): 1504-1509.
43. Gilligan AK, Markus R, Read S, Srikanth V, Hirano T, Fitt G et al. Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke. Stroke 2002; 33(9): 2236-2242.
44. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1588.
45. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke 1997; 28(11): 2109-2118.
46. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA et al. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA 2000; 283(9): 1151-1158.
47. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: A Cleveland update. Stroke 2003; 34(3): 799-800.
48. Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurru C, Biller J. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 2001; 32(1): 12-16.
49. Martin-Schild S, Hallevi H, Albright KC, Khaja AM, Barreto AD, Gonzales NR et al. Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke. Arch Neurol 2008; 65(9): 1174-1178.
50. Shanbrom E, Levy L. The role of systemic blood pressure in cerebral circulation in carotid and basilar artery thromboses; clinical observations and therapeutic implications of vasopressor agents. Am J Med 1957; 23(2): 197-204.
51. Shin HK, Nishimura M, Jones PB, Ay H, Boas DA, Moskowitz MA et al. Mild induced hypertension improves blood flow and oxygen metabolism in transient focal cerebral ischemia. Stroke 2008; 39(5): 1548-1555.
52. Hillis AE, Kane A, Tuffiash E, Ulatowski JA, Barker PB, Beauchamp NJ et al. Reperfusion of specific brain regions by raising blood pressure restores selective language functions in subacute stroke. Brain Lang 2001; 79(3): 495-510.
53. Koenig MA, Geocadin RG, de Grouchy M, Glasgow J, Vimal S, Restrepo L et al. Safety of induced hypertension therapy in patients with acute ischemic stroke. Neurocrit Care 2006; 4(1): 3-7.
54. Mistri AK, Robinson TG, Potter JF. Pressor therapy in acute ischemic stroke: Systematic review. Stroke 2006; 37(6): 1565-1571.
55. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25(5): 457-507.
56. Adams Jr HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115(20): E478-e534.
57. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19): 2560-2572.
58. Potter J, Robinson T, Ford G, James M, Jenkins D, Mistri A et al. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: Rationale and design. J Hypertens 2005; 23(3): 649-655.
59. Rosendorff C. New insights into hypertension management in acute stroke: let the CHHIPS fall where they may. J Clin Hypertens (Greenwich) 2008; 10(6): 425-426.
60. COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): Rationale and design. J Hypertens 2005; 23(2): 455-458.
61. Clinicaltrials.gov - Registry of federally and privately supported clinical trials conducted in the United States and around the world. Available at: www.clinicaltrials.gov. Accessed 30 September 2008.
62. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: The Oxfordshire Community Stroke Project. Stroke 1993; 24(6): 796-800.
63. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med 2001; 344 (19): 1450-1460.
64. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988; 19 (5): 547-554.
65. Fogelholm R, Avikainen S, Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 1997; 28(7): 1396-1400.
66. Qureshi AI, Safdar K, Weil J, Barch C, Bliwise DL, Colohan AR et al. Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 1995; 26 (10): 1764-1767.
67. Terayama Y, Tanahashi N, Fukuuchi Y, Gotoh F. Prognostic value of admission blood pressure in patients with intracerebral hemorrhage. Keio Cooperative Stroke Study. Stroke 1997; 28(6): 1185-1188.
68. Meyer JS, Bauer RB. Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology 1962; 12 36-47.
69. Bullock R, Brock-Utne J, van Dellen J, Blake G. Intracerebral hemorrhage in a primate model: Effect on regional cerebral blood flow. Surg Neurol 1988; 29(2): 101-107.
70. Nath FP, Kelly PT, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Effects of experimental intracerebral hemorrhage on blood flow, capillary permeability, and histochemistry. J Neurosurg 1987; 66(4): 555-562.
71. Kidwell CS, Saver JL, Mattiello J, Warach S, Liebeskind DS, Starkman S et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 2001; 57 (9): 1611-1617.
72. Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-h blood pressure decline and mortality after spontaneous intracerebral hemorrhage: A retrospective analysis with a random effects regression model. Crit Care Med 1999; 27(3): 480-485.
73. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28(1): 1-5.
74. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996; 27(10): 1783-1787.
75. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997; 28(12): 2370-2375.
76. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: Relationship between elevated blood pressure and hematoma enlargement. Stroke 2004; 35(6): 1364-1367.
77. Hirano T, Read SJ, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Egan GF et al. No evidence of hypoxic tissue on 18F-fluoromisonidazole PET after intracerebral hemorrhage. Neurology 1999; 53(9): 2179-2182.
78. Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology 1999; 52(2): 266-272.
79. Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001; 21(7): 804-810.
80. Butcher KS, Baird T, MacGregor L, Desmond P, Tress B, Davis S. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 2004; 35(8): 1879-1885.
81. Carhuapoma JR, Wang PY, Beauchamp NJ, Keyl PM, Hanley DF, Barker PB. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke 2000; 31(3): 726-732.
82. Schellinger PD, Fiebach JB, Hoffmann K, Becker K, Orakcioglu B, Kollmar R et al. Stroke MRI in intracerebral hemorrhage: Is there a perihemorrhagic penumbra? Stroke 2003; 34(7): 1674-1679.
83. Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 h) intracerebral hemorrhage. Neurology 2001; 57(1): 18-24.
84. Jauch EC, Lindsell CJ, Adeoye O, Khoury J, Barsan W, Broderick J et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 2006; 37(8): 2061-2065.
85. Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T et al. Determinants of intracerebral hemorrhage growth: An exploratory analysis. Stroke 2007; 38(3): 1072-1075.
86. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomized pilot trial. Lancet Neurol 2008; 7 (5): 391-399.
87. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D et al. Guidelines for the management of spontaneous intracerebral hemorrhAge in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation 2007; 116 (16): E391-e413.
88. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I et al. Recommendations for the management of intracranial haemorrhage - part I: Spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006; 22(4): 294-316.
89. Tietjen CS, Hurn PD, Ulatowski JA, Kirsch JR. Treatment modalities for hypertensive patients with intracranial pathology: Options and risks. Crit Care Med 1996; 24(2): 311-322.
90. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): Rationale and design. Neurocrit Care 2007; 6(1): 56-66.
91. Qureshi AI, The ATACH Investigators. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Trial. International Stroke Conference. New Orleans, LA, February 2008.